首页> 外文期刊>Osteoarthritis and cartilage >Effects of arginine-vasopressin and parathyroid hormone-related protein (1-34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis.
【24h】

Effects of arginine-vasopressin and parathyroid hormone-related protein (1-34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis.

机译:精氨酸-加压素和甲状旁腺激素相关蛋白(1-34)对类风湿关节炎和骨关节炎患者软骨细胞增殖和产生YKL-40的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Both arg-vasopressin (AVP) and parathyroid hormone-related protein (PTHrP) may act as proinflammatory hormones. In addition, they have been suggested to be involved in the pathophysiology of rheumatoid arthritis (RA). We therefore investigated the effects of AVP and PTHrP (1-34) on cell proliferation and secretion of the glycoprotein YKL-40 in human chondrocytes derived from healthy subjects as well as from patients with RA or osteoarthritis (OA). METHOD: Primary cultures of human chondrocytes were incubated with AVP (1-100 pmol/l) or PTHrP (1-34) (0.1-100 nmol/l). Cell proliferation was measured as [3H]thymidine incorporation. Intracellular cAMP and YKL-40 in cell medium were determined by commercially available kits. RESULTS: AVP and PTHrP (1-34) increased proliferation in chondrocytes derived from healthy donors as well as from RA and OA patients. PTHrP (1-34), but not AVP, increased intracellular levels of cAMP. PTHrP (1-34) did not change the amount of YKL-40 in chondrocytes from healthy subjects or patients with OA. AVP tended to decrease the secretion of YKL-40 from healthy chondrocytes. Both PTHrP (1-34) and AVP increased YKL-40 secretion from RA chondrocytes. In contrast, AVP decreased the secretion of YKL-40 in chondrocytes from patients with OA. CONCLUSION: AVP and PTHrP (1-34) stimulated proliferation in human chondrocytes derived from healthy subjects as well as from patients with RA or OA. However, the effects of AVP and PTHrP (1-34) on YKL-40 secretion varied depending on the origin of the chondrocytes.
机译:目的:精氨酸加压素(AVP)和甲状旁腺激素相关蛋白(PTHrP)均可作为促炎激素。另外,已经建议它们参与类风湿关节炎(RA)的病理生理。因此,我们研究了AVP和PTHrP(1-34)对健康受试者以及RA或骨关节炎(OA)患者来源的人软骨细胞中细胞增殖和糖蛋白YKL-40分泌的影响。方法:将人类软骨细胞的原代培养物与AVP(1-100 pmol / l)或PTHrP(1-34)(0.1-100 nmol / l)孵育。通过[3 H]胸苷掺入来测量细胞增殖。用市售试剂盒测定细胞培养基中的细胞内cAMP和YKL-40。结果:AVP和PTHrP(1-34)增加了来自健康供体以及RA和OA患者的软骨细胞的增殖。 PTHrP(1-34)而不是AVP增加细胞内cAMP水平。 PTHrP(1-34)不会改变健康受试者或OA患者的软骨细胞中YKL-40的量。 AVP倾向于减少健康软骨细胞分泌YKL-40。 PTHrP(1-34)和AVP均可增加RA软骨细胞的YKL-40分泌。相反,AVP降低了OA患者软骨细胞中YKL-40的分泌。结论:AVP和PTHrP(1-34)刺激了健康受试者以及RA或OA患者的人软骨细胞的增殖。但是,AVP和PTHrP(1-34)对YKL-40分泌的影响取决于软骨细胞的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号